Quest Diagnostics
DGX
#1219
Rank
$14.73 B
Marketcap
$133.11
Share price
1.56%
Change (1 day)
-4.09%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Quest Diagnostics (DGX) - P/B ratio

P/B ratio as of March 2024 : 2.30

According to Quest Diagnostics 's latest financial reports the company has a price-to-book ratio of 2.30.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Quest Diagnostics - P/B ratio (from 2001 to 2023)

P/B ratio by year

Year P/B ratio Change
2023-12-312.42-18.56%
2022-12-312.97-8.3%
2021-12-313.2338.78%
2020-12-312.33-5.43%
2019-12-312.4617.16%
2018-12-312.10-21.1%
2017-12-312.67-0.87%
2016-12-312.6926.46%
2015-12-312.13-4.63%
2014-12-312.2314.93%
2013-12-311.94-11.95%
2012-12-312.20-10.61%
2011-12-312.478.49%
2010-12-312.27-17.62%
2009-12-312.76-2.05%
2008-12-312.82-8.83%
2007-12-313.09-9.25%
2006-12-313.40-7.92%
2005-12-313.70-12.48%
2004-12-314.2334.6%
2003-12-313.14-0.39%
2002-12-313.15

P/B ratio for similar companies or competitors

Company P/B ratio differencediff. Country
2.33 1.41%๐Ÿ‡บ๐Ÿ‡ธ USA
2.34 2.04%๐Ÿ‡บ๐Ÿ‡ธ USA
2.13-7.21%๐Ÿ‡บ๐Ÿ‡ธ USA
2.50 8.84%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
0.9192-59.97%๐Ÿ‡บ๐Ÿ‡ธ USA